IPS Cell Derived Organoids Market Research Report Information by Type (Brain Organoids, Heart Organoids, Lung Organoids, Liver Organoids, Kidney Organoids, and Others), by Application (Drug Discovery and Development, Disease Modelling, and Regenerative Medicine), by End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Contract Research Organization), and by Region (North America, Europe, Asia-Pacific, and Rest of the World - Forecast till 2032
Overview of the Market
IPS Cell Derived Organoids Market size was valued at USD 0.44 billion in 2023. The IPS Cell Derived Organoids Market industry is projected to grow from USD 0.51 billion in 2024 to USD 1.89 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 17.8% during the forecast period (2024 - 2032).
IPS cell-derived organoids market represent a revolutionary advancement in biomedical research and drug development. These miniature, three-dimensional tissue models, generated from induced pluripotent stem cells (iPSCs), offer unprecedented opportunities for studying human physiology, disease mechanisms, and drug efficacy. Organoids are used in various applications, including disease modelling, drug discovery, personalized medicine, and regenerative therapies. The iPS cell-derived organoids market is poised for substantial growth, driven by technological advancements, increasing demand for personalized medicine, and expanding applications in drug discovery and regenerative medicine. However, overcoming technical, regulatory, and ethical challenges will be crucial for realizing the full potential of this transformative technology.
Perspectives on Market Segments
The IPS Cell Derived Organoids Market segmentation, based on type, includes Brain Organoids, Heart Organoids, Lung Organoids, Liver Organoids, Kidney Organoids, and Others.
The IPS Cell Derived Organoids Market segmentation, based on application, includes drug discovery and development, disease modelling, and regenerative medicine.
Market Regional Insights
The IPS Cell Derived Organoids market in America boasts a robust research infrastructure, substantial investments in life sciences, and a thriving biotechnology industry. North America is home to several top-tier universities and research centers that are at the forefront of stem cell research. This region has seen substantial investments from both public and private sectors aimed at advancing the development and application of iPS cell-derived organoids. The well-established healthcare systems in North America facilitate the adoption of advanced medical technologies. The presence of sophisticated laboratory facilities and skilled professionals further supports market growth. The region's inclination towards technological adoption has fostered the development and application of organoid-based platforms. Supportive regulatory frameworks encourage investments in organoid research and development.
Europe IPS Cell Derived Organoids market accounted for the second-largest market share due to region's emphasis on healthcare, coupled with a strong scientific community, drives the market. Furthermore, the Germany IPS Cell Derived Organoids provider attributed to hold the largest market share, and the France IPS Cell Derived Organoids providers is projected be the fastest growing market in the Europe region.
The Asia-Pacific IPS Cell Derived Organoids market is expected to be the fastest growing from 2023 to 2032 due to increasing investments in biomedical research, growing healthcare expenditure, and a rising prevalence of chronic diseases can support IPS Cell Derived Organoids development.
Key Players
Key Companies in the IPS Cell Derived Organoids market includes ACROBiosystems (US), Miltenyi Biotec (Germany), ThermoFisher Scientific (US), STEMCELL Technologies (Canada), Bio-Techne (US), Merck KGaA (Germany), Molecular Devices, LLC (US), Corning Incorporated (US), Promega Corporation (US), and Creative Bioarray (US).
圖表清單 List of Tables & Figures
LIST OF TABLES
TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT
TABLE 2 GLOBAL: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 3 GLOBAL: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 4 GLOBAL: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 5 GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET, BY REGION, 2019–2032 (USD MILLION)
TABLE 6 NORTH AMERICA: IPS CELL-DERIVED ORGANOIDS MARKET, BY COUNTRY, 2019–2032 (USD MILLION)
TABLE 7 NORTH AMERICA: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 8 NORTH AMERICA: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 9 NORTH AMERICA: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 10 USA: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 11 USA: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 12 USA: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 13 CANADA: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 14 CANADA: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 15 CANADA: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 16 EUROPE: IPS CELL-DERIVED ORGANOIDS MARKET, BY COUNTRY, 2019–2032 (USD MILLION)
TABLE 17 EUROPE: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 18 EUROPE: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 19 EUROPE: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 20 GERMANY: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 21 GERMANY: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 22 GERMANY: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 23 UK: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 24 UK: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 25 UK: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 26 FRANCE: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 27 FRANCE: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 28 FRANCE: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 29 ITALY: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 30 ITALY: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 31 ITALY: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 32 SPAIN: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 33 SPAIN: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 34 SPAIN: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 35 REST OF EUROPE: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 36 REST OF EUROPE: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 37 REST OF EUROPE: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 38 ASIA PACIFIC: IPS CELL-DERIVED ORGANOIDS MARKET, BY COUNTRY, 2019–2032 (USD MILLION)
TABLE 39 ASIA PACIFIC: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 40 ASIA PACIFIC: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 41 ASIA PACIFIC: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 42 CHINA: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 43 CHINA: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 44 CHINA: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 45 INDIA: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 46 INDIA: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 47 INDIA: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 48 JAPAN: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 49 JAPAN: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 50 JAPAN: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 51 SOUTH KOREA: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 52 SOUTH KOREA: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 53 SOUTH KOREA: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 54 AUSTRALIA: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 55 AUSTRALIA: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 56 AUSTRALIA: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 57 REST OF APAC: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 58 REST OF APAC: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 59 REST OF APAC: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 60 REST OF THE WORLD: IPS CELL-DERIVED ORGANOIDS MARKET, BY COUNTRY, 2019–2032 (USD MILLION)
TABLE 61 REST OF WORLD: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 62 REST OF WORLD: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 63 REST OF WORLD: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 64 MIDDLE EAST & AFRICA: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 65 MIDDLE EAST & AFRICA: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 66 MIDDLE EAST & AFRICA: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 67 SOUTH AMERICA: IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 68 SOUTH AMERICA: IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 69 SOUTH AMERICA: IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 70 ACROBIOSYSTEMS: PRODUCTS OFFERED
TABLE 71 ACROBIOSYSTEMS: KEY DEVELOPMENTS
TABLE 72 MILTENYI BIOTEC: PRODUCTS OFFERED
TABLE 73 THERMO FISHER SCIENTIFIC INC: PRODUCTS OFFERED
TABLE 74 STEMCELL TECHNOLOGIES: PRODUCTS OFFERED
TABLE 75 BIO-TECHNE CORP: PRODUCTS OFFERED
TABLE 76 MERCK KGAA: PRODUCTS OFFERED
TABLE 77 MOLECULAR DEVICES.: PRODUCTS OFFERED
TABLE 78 CORNING INCORPORATED: PRODUCTS OFFERED
TABLE 79 PROMEGA CORPORATION.: PRODUCTS OFFERED
TABLE 80 CREATIVE BIOARRAY: PRODUCTS OFFERED
LIST OF FIGURES
FIGURE 1 GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET: STRUCTURE
FIGURE 2 MARKET DYNAMICS: GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET
FIGURE 3 DRIVER IMPACT ANALYSIS: GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET
FIGURE 4 RESTRAINT IMPACT ANALYSIS: GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET
FIGURE 5 PORTER’S FIVE FORCES ANALYSIS: GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET
FIGURE 6 SUPPLY CHAIN ANALYSIS: GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET
FIGURE 7 GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2023 (% SHARE)
FIGURE 8 GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET, BY TYPE, 2019–2032 (USD MILLION)
FIGURE 9 GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET, BY APPLICATION, 2023 (% SHARE)
FIGURE 10 GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET, BY PRICING, 2019–2032 (USD MILLION)
FIGURE 11 GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET, BY END USER, 2023 (% SHARE)
FIGURE 12 GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET, BY AGE CATEGORY, 2019–2032 (USD MILLION)
FIGURE 13 GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET, BY REGION, 2023 (% SHARE)
FIGURE 14 GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET, BY REGION, 2019-2032 (USD MILLION)
FIGURE 15 NORTH AMERICA: IPS CELL-DERIVED ORGANOIDS MARKET SHARE, BY COUNTRY, 2023 (% SHARE)
FIGURE 16 EUROPE: IPS CELL-DERIVED ORGANOIDS MARKET SHARE, BY COUNTRY, 2023 (% SHARE)
FIGURE 17 ASIA PACIFIC: IPS CELL-DERIVED ORGANOIDS MARKET SHARE, BY COUNTRY, 2023 (% SHARE)
FIGURE 18 MIDDLE EAST & AFRICA: IPS CELL-DERIVED ORGANOIDS MARKET SHARE, BY COUNTRY, 2023 (% SHARE)
FIGURE 19 COMPETITOR DASHBOARD: GLOBAL IPS CELL-DERIVED ORGANOIDS MARKET
FIGURE 20 ACROBIOSYSTEMS: SWOT ANALYSIS
FIGURE 21 MILTENYI BIOTEC: SWOT ANALYSIS
FIGURE 22 THERMO FISHER SCIENTIFIC INC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 23 THERMO FISHER SCIENTIFIC INC: SWOT ANALYSIS
FIGURE 24 STEMCELL TECHNOLOGIES: SWOT ANALYSIS
FIGURE 25 MERCK KGAA: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 26 MERCK KGAA: SWOT ANALYSIS
FIGURE 27 CORNING INCORPORATED: FINANCIAL OVERVIEW SNAPSHOT
量子訊息有限公司為 Market Research Future 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們